Zyla Life Sciences Sustainability Profile
Zyla Life Sciences, headquartered in the United States, is a prominent player in the life sciences industry, specialising in innovative healthcare solutions. Founded in recent years, the company has quickly established itself in key operational regions across North America and beyond. Zyla Life Sciences focuses on developing and commercialising unique pharmaceutical products, particularly in pain management and related therapeutic areas. Their commitment to research and development has led to the introduction of several groundbreaking treatments that stand out for their efficacy and safety profiles. With a strong market position, Zyla Life Sciences has achieved notable milestones, including strategic partnerships and a growing portfolio of proprietary products. The company continues to drive advancements in healthcare, aiming to improve patient outcomes and enhance quality of life.
DitchCarbon Score
How does Zyla Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zyla Life Sciences's score of 25 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zyla Life Sciences's reported carbon emissions
Zyla Life Sciences, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported figures. The company is a current subsidiary of Assertio Holdings, Inc., which may influence its climate commitments and reporting practices. Despite the lack of direct emissions data, Zyla Life Sciences is part of a corporate family that may have broader sustainability initiatives. However, there are no documented reduction targets or climate pledges from Zyla Life Sciences itself, nor are there any specific initiatives reported under the Science Based Targets initiative (SBTi) or other climate frameworks. As a subsidiary, Zyla Life Sciences may align its environmental strategies with those of Assertio Holdings, Inc., but specific details on emissions or reduction targets have not been disclosed. The absence of data suggests that Zyla Life Sciences may still be in the process of establishing its own climate commitments or reporting mechanisms.
How Carbon Intensive is Zyla Life Sciences's Industry?
How Carbon Intensive is Zyla Life Sciences's Location?
Zyla Life Sciences's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Zyla Life Sciences has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
